Decoy Therapeutics is trading 5.6% down now at $2.72, with no clear company-specific catalyst identified.

  • No clear company-specific announcement, filing, earnings release, or major event for September 4, 2026 was identified.
  • Latest indexed company coverage concerns earlier pipeline milestones rather than today’s decline.
  • Broader markets are lower after stronger-than-expected U.S. employment data increased rate-hike concerns, but available evidence does not establish a direct catalyst for the larger move.